Tanaka, T., Nakazawa, H., Kuriyama, N., & Kaneki, M. (2018). Farnesyltransferase inhibitors prevent HIV protease inhibitor (lopinavir/ritonavir)-induced lipodystrophy and metabolic syndrome in mice. Exp Ther Med.
Styl ChicagoTanaka, Tomokazu, Harumasa Nakazawa, Naohide Kuriyama, a Masao Kaneki. "Farnesyltransferase Inhibitors Prevent HIV Protease Inhibitor (lopinavir/ritonavir)-induced Lipodystrophy and Metabolic Syndrome in Mice." Exp Ther Med 2018.
Citace podle MLATanaka, Tomokazu, Harumasa Nakazawa, Naohide Kuriyama, a Masao Kaneki. "Farnesyltransferase Inhibitors Prevent HIV Protease Inhibitor (lopinavir/ritonavir)-induced Lipodystrophy and Metabolic Syndrome in Mice." Exp Ther Med 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..